Login / Signup

Effectiveness of immunotherapies in relapsing myelin oligodendrocyte glycoprotein antibody-associated disease.

Philippe Antoine BilodeauAnastasia VishnevetskyNegar MolazadehItay LotanMonique AndersonGabriela RomanowRebecca SalkyBrian C HealyMarcelo MatielloTanuja ChitnisMichael Levy
Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
IVIG had the lowest ARRs and IRRs compared to pre-treatment and the highest relapse-freedom odds ratio compared to prednisone, while BCD had the lowest. In pediatric-onset MOGAD, MMF had the lowest ARRs.
Keyphrases
  • multiple sclerosis
  • randomized controlled trial
  • systematic review
  • disease activity
  • combination therapy
  • systemic lupus erythematosus